Aegerion Pharmaceuticals (AEGR)
|
26.51
-0.09 (-0.34%)
|
|
|
|
AEGR additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
AEGR Profile
•
Exchange
NASDAQ
•
Sector
Not Available
•
Industry
Not Available
•
Held by these Mutual Funds
Not Available
•
Executives
Mr. Marc D. Beer
Chief Exec. Officer and Director
Mr. Mark J. Fitzpatrick
Chief Financial Officer and Principal Accounting Officer
Ms. Martha J. Carter Rac
Chief Regulatory Officer and Sr. VP
Dr. Mark Sumeray M.D. S.
FRCS 46
Chief Medical Officer
Mr. Mark A. Rothera r>Global Pres
Chief Exec. Officer and Director
Mr. Mark J. Fitzpatrick
Chief Financial Officer and Principal Accounting Officer
Ms. Martha J. Carter Rac
Chief Regulatory Officer and Sr. VP
Dr. Mark Sumeray M.D. S.
FRCS 46
Chief Medical Officer
Mr. Mark A. Rothera r>Global Pres
•
Employee Count
60
Special Offers
Competitors
AEGR earnings
Date
Actual
Expected
Prev Yr Qtr
11/7/2012
-0.59
-0.56
-0.48
8/8/2012
-0.63
-0.51
-0.49
5/1/2012
-0.51
-0.54
-0.39
